{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:28:42Z","timestamp":1762079322012},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP 64310"],"award-info":[{"award-number":["MOP 64310"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.peptides.2012.02.014","type":"journal-article","created":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T18:15:28Z","timestamp":1331403328000},"page":"9-13","source":"Crossref","is-referenced-by-count":8,"title":["CCK-B receptor gene and response to cholecystokinin-tetrapeptide in healthy volunteers"],"prefix":"10.1016","volume":"35","author":[{"given":"Diana","family":"Koszycki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Prichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra J.","family":"Fiocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakov","family":"Shlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bradwejn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2012.02.014_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-1781(96)02948-4","article-title":"Emotional and cognitive factors associated with response to CCK-4 in health volunteers","volume":"66","author":"Aluoja","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.peptides.2012.02.014_bib0010","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1523\/JNEUROSCI.21-01-00262.2001","article-title":"Enhanced cortical extracellular levels in cholecystokinin-like material in a model of anticipation of social defeat in the rat","volume":"21","author":"Becker","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.peptides.2012.02.014_bib0015","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1176\/ajp.152.8.1180","article-title":"Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers","volume":"152","author":"Benkelfat","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1067\/mai.2001.114798","article-title":"Idiopathic environmental intolerance: increased prevalence of panic-disorder associated cholecystokinin B receptor allele 7","volume":"107","author":"Binkley","year":"2001","journal-title":"J Allerg Clin Immunol"},{"issue":"Suppl. 234","key":"10.1016\/j.peptides.2012.02.014_bib0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/713783681","article-title":"Cholecystokinin and panic disorder: past and future clinical research strategies","volume":"61","author":"Bradwejn","year":"2001","journal-title":"Scan J Clin Lab Invest"},{"key":"10.1016\/j.peptides.2012.02.014_bib0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","article-title":"Enhanced sensitivity to cholecystokin-tetrapeptide in panic disorder","volume":"48","author":"Bradwejn","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0035","series-title":"NEO PI-R professional manual","author":"Costa","year":"1992"},{"key":"10.1016\/j.peptides.2012.02.014_bib0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hbm.20522","article-title":"Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers","volume":"30","author":"Eser","year":"2009","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.peptides.2012.02.014_bib0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-007-0738-7","article-title":"Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study","volume":"192","author":"Eser","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.peptides.2012.02.014_bib0055","series-title":"Structured Clinical Interview for DSM IV-Non-Patient Edition.","author":"First","year":"1995"},{"key":"10.1016\/j.peptides.2012.02.014_bib0060","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0306-4530(00)00015-9","article-title":"Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects","volume":"25","author":"Flint","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.peptides.2012.02.014_bib0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1176\/ajp.155.2.283","article-title":"Effect of aging on cholecystokinin-induced panic","volume":"155","author":"Flint","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1176\/ajp.146.2.148","article-title":"A neuroanatomical hypothesis for panic disorder","volume":"146","author":"Gorman","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0075","first-page":"81","article-title":"Acute effects of cholecystokinin tetrapeptide on brain stem auditory evoked potentials in healthy volunteers","volume":"36","author":"Gunnarsson","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.mp.4000788","article-title":"No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder","volume":"6","author":"Hamilton","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0165-6147(93)90020-K","article-title":"CCK in animals and human research","volume":"14","author":"Harro","year":"1993","journal-title":"Trends Pharm Sci"},{"key":"10.1016\/j.peptides.2012.02.014_bib0090","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ajmg.10043","article-title":"Association studies of the CT repeat polymorphism in the 5\u2019 upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects","volume":"105","author":"Hattori","year":"2001","journal-title":"Am J Med Gen"},{"issue":"Suppl","key":"10.1016\/j.peptides.2012.02.014_bib0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-7091-0579-5_17","article-title":"Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder","volume":"68","author":"Hosing","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.peptides.2012.02.014_bib0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00006842-199805000-00020","article-title":"Gastrin, cholecystokinin, and somatostatin in a laboratory experiment of patients with funcitonal dyspepsia","volume":"60","author":"Jonsson","year":"1998","journal-title":"Psychosom Med"},{"key":"10.1016\/j.peptides.2012.02.014_bib0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/da.20012","article-title":"Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder","volume":"20","author":"Katzman","year":"2004","journal-title":"Depres Anx"},{"key":"10.1016\/j.peptides.2012.02.014_bib0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s002130050371","article-title":"Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder","volume":"133","author":"Kellner","year":"1997","journal-title":"Psychopharmcology"},{"key":"10.1016\/j.peptides.2012.02.014_bib0115","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jpsychires.2008.09.001","article-title":"The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype","volume":"43","author":"Kellner","year":"2009","journal-title":"J Psychiatry Res"},{"key":"10.1016\/j.peptides.2012.02.014_bib0120","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.mp.4000507","article-title":"Investigation of cholecystokinin system genes in panic disorder","volume":"4","author":"Kennedy","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-1781(96)02819-3","article-title":"Influence of personality on behavioural response to cholecystokinin-tetrapeptide in patients with panic disorder","volume":"62","author":"Koszycki","year":"1996","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.peptides.2012.02.014_bib0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0165-0327(03)00110-1","article-title":"Sensitivity to cholecystokinin-tetrapeptide in major depression","volume":"80","author":"Koszycki","year":"2004","journal-title":"J Affect Dis"},{"key":"10.1016\/j.peptides.2012.02.014_bib0135","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1176\/ajp.150.12.1881","article-title":"Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers","volume":"150","author":"Koszycki","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G","article-title":"Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers","volume":"8","author":"Koszycki","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.peptides.2012.02.014_bib0145_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0893-133X(98)00057-8","article-title":"Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during the follicular and luteal phases","volume":"20","author":"Le Melledo","year":"1999","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.peptides.2012.02.014_bib0145_2","first-page":"605","article-title":"Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during the follicular and luteal phases","volume":"52","author":"Le Melledo","year":"1995","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.peptides.2012.02.014_bib0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-0327(79)90021-1","article-title":"The Hopkins Symptom Checklist (HSCL)-factors derived from the HSCL-90","volume":"1","author":"Lipman","year":"1979","journal-title":"J Affect Dis"},{"key":"10.1016\/j.peptides.2012.02.014_bib0155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/mp.2009.145","article-title":"Advances in molecular genetics of panic disorder","volume":"15","author":"Maron","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00041444-200503000-00004","article-title":"Association study of 90 candidate gene polymorphisms in panic disorder","volume":"15","author":"Maron","year":"2005","journal-title":"Psychiatry Genet"},{"key":"10.1016\/j.peptides.2012.02.014_bib0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2008.09.052","article-title":"Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteeers","volume":"446","author":"Maron","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2012.02.014_bib0170","series-title":"Manual for the Family Interview for Genetic Studies","author":"Maxwell","year":"1992"},{"key":"10.1016\/j.peptides.2012.02.014_bib0175","first-page":"445","article-title":"International union of pharmacology: XXI: Structure, distribution and functions of cholecystokinin","author":"Noble","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.peptides.2012.02.014_bib0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajmg.b.30035","article-title":"Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder","volume":"129B","author":"Perna","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.peptides.2012.02.014_bib0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0196-9781(92)90150-2","article-title":"Cholecystokinin, gastrin and stress hormone response in marathon runners","volume":"13","author":"Philipp","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.02.014_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-7967(86)90143-9","article-title":"Anxiety sensitivity, anxiety frequency, and the prediction of fearfulness","volume":"24","author":"Reiss","year":"1986","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.peptides.2012.02.014_bib0195","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1037\/0021-843X.109.2.308","article-title":"Evaluating gene x psychological risk factor effects in the pathogenesis of anxiety: a new model approach","volume":"109","author":"Schmidt","year":"2000","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.peptides.2012.02.014_bib0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0269881110372543","article-title":"Genetic moderation of CO2-induced fear by 5-HTTLPR genotype","volume":"25","author":"Schruers","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.peptides.2012.02.014_bib0205","first-page":"332","article-title":"Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin-tetrapeptide challenge in patients with panic disorder","volume":"22","author":"Shlik","year":"1997","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.peptides.2012.02.014_bib0210","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0006-3223(03)00598-5","article-title":"Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition","volume":"54","author":"Smoller","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biopsych.2004.05.020","article-title":"A polymorphism of the \u03b21-adrenergic receptor is associated with low extraversion","volume":"56","author":"Stein","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.014_bib0220","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.npp.1301422","article-title":"Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders","volume":"33","author":"Stein","year":"2008","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.peptides.2012.02.014_bib0225","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.psychres.2010.04.003","article-title":"Association between personality traits and CCK-4-induced panic attacks in healthy volunteers","volume":"178","author":"T\u00f5ru","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.peptides.2012.02.014_bib0050","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00702-008-0047-2","article-title":"Impact of state and trait anxiety on the panic response to CCK-4","volume":"115","author":"Eser","year":"2008","journal-title":"J Neural Transm"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112000757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112000757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T01:11:00Z","timestamp":1687309860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978112000757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0196978112000757"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2012.02.014","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}